Table 5.

Description of the whole dataset for the mycotoxins analysed in serum samples.

Group	Observations	% Positive	Mean (ng/mL)	Std Dev (ng/mL)	Min–Max (ng/mL)	Median (ng/mL)
Whole Group	213/233 *
GLIO		21.2%	2.3	4.3	0–28.4	0.0
OTA		82.9%	0.36	0.29	0–1.76	0.35
AFB1		22.9%	0.01	0.05	0–0.73	0.00
AFM1		50.2%	0.11	0.18	0–1.91	0.11
ZEA		5.4%	0.1	0.4	0–3.9	0.0
DON		19.5%	1.0	3.6	0–27.9	0.0
DOM1		13.1%	0.3	1.1	0–12.7	0.0
FB1		13.7%	0.2	0.7	0–5.6	0.0
Autistic Group	160
GLIO		23.0%	1.8	4.5	0–28.4	0.0
OTA		85.1%	0.39	0.31	0–1.76	0.35
AFB1		24.0%	0.01	0.06	0–0.73	0.00
AFM1		53.2%	0.12	0.20	0–1.91	0.11
ZEA		5.2%	0.1	0.4	0–3.9	0.00
DON		19.5%	1.2	3.9	0–27.9	0.0
DOM1		12.9%	0.3	1.2	0–12.7	0.0
FB1		17.5%	0.3	0.7	0–5.6	0.0
Siblings	35
GLIO		14.3%	0.6	1.8	0–5.6	0.0
OTA		77.1%	0.27	0.21	0–0.79	0.29
AFB1		25.7%	0.002	0.00	0–0.01	0.00
AFM1		45.7%	0.07	0.10	0–0.36	0.00
ZEA		8.6%	0.1	0.2	0–1.2	0.0
DON		22.9%	0.5	0.9	0–2.3	0.0
DOM1		17.1%	0.3	0.6	0–1.6	0.0
FB1		2.9%	0.04	0.3	0–1.5	0.0
Non-Parental	18
GLIO		18.8%	10.3	33.3	0–1	0.0
OTA		75.0%	0.28	0.2	0–0.61	0.35
AFB1		6.3%	0.00	0.002	0–0.01	0.00
AFM1		31.3%	0.06	0.11	0–0.33	0.00
ZEA		0.0%	0.00	0.0	0–0.0	0.0
DON		12.5%	0.8	2.8	0–11.0	0.0
DOM1		6.3%	0.1	0.3	0–1.4	0.0
FB1		0.0%	0.0	0.0	0–0.0	0.0

* Due to the low amount of samples collected from some children, it was not always possible to carry out all the analyses planned for the study.